{"id":263,"date":"2026-10-18T18:43:58","date_gmt":"2026-10-18T16:43:58","guid":{"rendered":"https:\/\/livingevidenceihd.com\/lesrepo\/"},"modified":"2026-11-11T17:44:34","modified_gmt":"2026-11-11T16:44:34","slug":"lesrepo","status":"publish","type":"page","link":"https:\/\/livingevidenceihd.com\/es\/lesrepo\/","title":{"rendered":"Repositorio LE-Synthesis"},"content":{"rendered":"\n<div class=\"wp-block-group le-page is-layout-constrained wp-block-group-is-layout-constrained\">\n<div class=\"wp-block-group le-sec-head le-sec-head--page is-nowrap is-layout-flex wp-container-core-group-is-layout-0ce06dcb wp-block-group-is-layout-flex\">\n<figure class=\"wp-block-image size-thumbnail le-sec-icon wp-container-content-db1313a3\"><img loading=\"lazy\" decoding=\"async\" width=\"150\" height=\"150\" src=\"https:\/\/livingevidenceihd.com\/wp-content\/uploads\/2026\/11\/simple-logo-lgreen-150x150.webp\" alt=\"\" class=\"wp-image-133\" srcset=\"https:\/\/livingevidenceihd.com\/wp-content\/uploads\/2026\/11\/simple-logo-lgreen-150x150.webp 150w, https:\/\/livingevidenceihd.com\/wp-content\/uploads\/2026\/11\/simple-logo-lgreen.webp 200w\" sizes=\"auto, (max-width: 150px) 100vw, 150px\" \/><\/figure>\n\n\n\n<h1 class=\"wp-block-heading le-sec-title\">Repositorio LE-Synthesis<\/h1>\n<\/div>\n\n\n\n<p class=\"le-lead wp-block-paragraph\">El programa LE-IHD ha apoyado el desarrollo de diversas s\u00edntesis de evidencia viva por parte de distintas organizaciones. Mediante este repositorio de acceso gratuito, respaldamos el ecosistema de la evidencia al evitar la duplicaci\u00f3n de esfuerzos entre grupos, y fomentamos la reutilizaci\u00f3n de la evidencia en los procesos de generaci\u00f3n y adaptaci\u00f3n de recomendaciones.<br><br>Todos los documentos publicados en este repositorio han sido sometidos a revisi\u00f3n por pares antes de su publicaci\u00f3n, est\u00e1n registrados en el Open Science Framework y su citaci\u00f3n debe incluir el DOI correspondiente.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-text-color has-alpha-channel-opacity has-background le-hr is-style-wide\" style=\"background-color:#9acc32;color:#9acc32\"\/>\n\n\n\n<h3 class=\"wp-block-heading le-sub-title\">En curso<\/h3>\n\n\n\n<div style=\"height:10px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<details class=\"wp-block-details le-acc le-acc--repo is-layout-flow wp-block-details-is-layout-flow\"><summary>Terapia con c\u00e9lulas T con receptor de ant\u00edgeno quim\u00e9rico para neoplasias hematol\u00f3gicas<\/summary>\n<p class=\"le-doc wp-block-paragraph\"><a href=\"\/pdfs\/PROTOCOL_LES_CAR-T_HematolMalignancies.pdf\" data-type=\"link\" data-id=\"\/pdfs\/PROTOCOL_LES_CAR-T_HematolMalignancies.pdf\">Protocol<\/a><\/p>\n\n\n\n<p class=\"le-doc wp-block-paragraph\"><a href=\"\/pdfs\/BASELINE_LES_CAR-T_HematolMalignancies.pdf\" data-type=\"link\" data-id=\"\/pdfs\/BASELINE_LES_CAR-T_HematolMalignancies.pdf\">Baseline Report<\/a><\/p>\n\n\n\n<p class=\"le-doc wp-block-paragraph\"><a href=\"\/pdfs\/UPDATE%20REPORT_LESS_CAR-T_HematolMalignancies.pdf\" data-type=\"link\" data-id=\"\/pdfs\/UPDATE%20REPORT_LESS_CAR-T_HematolMalignancies.pdf\">Updated Reports<\/a><\/p>\n\n\n\n<p class=\"le-doc wp-block-paragraph\"><a href=\"https:\/\/drive.google.com\/drive\/folders\/1lJKAAzXaofrUpdJ2DVk62L71z5H-mn5N\">Evidence Surveillance<\/a><\/p>\n\n\n\n<p class=\"le-doc wp-block-paragraph\"><a href=\"https:\/\/app.iloveevidence.com\/loves\/60a515783d05155d670f4f6d?question_domain=5b1dcd8ae611de7ae84e8f14&amp;population=5d4a749c69c00e69c91e5ff5&amp;intervention=60a4e5ac69c00e3874b51aa6&amp;classification=all\">See in L.OVE<\/a><\/p>\n\n\n\n<p class=\"le-doc le-doc--label wp-block-paragraph\">Publicaciones<\/p>\n\n\n\n<p class=\"le-pub wp-block-paragraph\"><a href=\"https:\/\/doi.org\/10.1177\/20406207231168211\">Saiz LC, Leache L&#8230; CAR-T therapy in hematologic malignancies<\/a><\/p>\n<\/details>\n\n\n\n<details class=\"wp-block-details le-acc le-acc--repo is-layout-flow wp-block-details-is-layout-flow\"><summary>Eficacia y seguridad de la estimulaci\u00f3n cerebral profunda en el trastorno obsesivo-compulsivo grave y resistente<\/summary>\n<p class=\"le-doc wp-block-paragraph\"><a href=\"\/pdfs\/PROTOCOL_LES_BrainStim_ResistObsesCompulsDis.pdf\" data-type=\"link\" data-id=\"\/pdfs\/PROTOCOL_LES_BrainStim_ResistObsesCompulsDis.pdf\">Protocol<\/a><\/p>\n\n\n\n<p class=\"le-doc wp-block-paragraph\"><a href=\"\/pdfs\/Baseline_synthesis_Brain_Stimulation_LE-IHD_Avalia-t.pdf\" data-type=\"link\" data-id=\"\/pdfs\/Baseline_synthesis_Brain_Stimulation_LE-IHD_Avalia-t.pdf\">Baseline Report<\/a><\/p>\n\n\n\n<p class=\"le-doc wp-block-paragraph\"><a href=\"https:\/\/drive.google.com\/drive\/folders\/1VPUd9vxRGWfhH91NbEzx_dDcvcqxEdMw\">Evidence Surveillance<\/a><\/p>\n\n\n\n<p class=\"le-doc wp-block-paragraph\"><a href=\"https:\/\/app.iloveevidence.com\/loves\/6442a0185d935300087c89ff?question_domain=5b1dcd8ae611de7ae84e8f14&amp;population=6442b6d7206f2b00076f6a76&amp;intervention=64418d822dfa8e00086a4c99&amp;classification=all\">See in L.OVE<\/a><\/p>\n\n\n\n<p class=\"le-doc le-doc--label wp-block-paragraph\">Publicaciones<\/p>\n<\/details>\n\n\n\n<details class=\"wp-block-details le-acc le-acc--repo is-layout-flow wp-block-details-is-layout-flow\"><summary>Embolizaci\u00f3n de las arterias geniculares en pacientes con dolor de rodilla secundario a artrosis, refractario al tratamiento habitual<\/summary>\n<p class=\"le-doc wp-block-paragraph\"><a href=\"\/pdfs\/PROTOCOL_LES_GenArtEmb_Osteoartritis.pdf\" data-type=\"link\" data-id=\"\/pdfs\/PROTOCOL_LES_GenArtEmb_Osteoartritis.pdf\">Protocol<\/a><\/p>\n\n\n\n<p class=\"le-doc wp-block-paragraph\"><a href=\"\/pdfs\/Baseline_synthesis_GAE_21_02_2024.pdf\">Baseline Report<\/a><\/p>\n\n\n\n<p class=\"le-doc wp-block-paragraph\"><a href=\"\/pdfs\/Update_report_GAE_20_11_2025_rev_01082025.pdf\" data-type=\"link\" data-id=\"\/pdfs\/Update_report_GAE_20_11_2025_rev_01082025.pdf\">Updated Reports<\/a><\/p>\n\n\n\n<p class=\"le-doc wp-block-paragraph\"><a href=\"https:\/\/drive.google.com\/drive\/folders\/1kGuLnrGzcpsMVxi1xh22SyHvjid4OYJC\">Evidence Surveillance<\/a><\/p>\n\n\n\n<p class=\"le-doc wp-block-paragraph\"><a href=\"https:\/\/app.iloveevidence.com\/loves\/58c04f21d56e642e050aee10?question_domain=5b1dcd8ae611de7ae84e8f14&amp;population=5d1498e1daeedf730326b7be&amp;intervention=64257d4edc36eb00073b7f30&amp;classification=systematic-review\">See in L.OVE<\/a><\/p>\n\n\n\n<p class=\"le-doc le-doc--label wp-block-paragraph\">Publicaciones<\/p>\n\n\n\n<p class=\"le-pub wp-block-paragraph\"><a href=\"https:\/\/doi.org\/10.1016\/j.gaceta.2025.102459\">Hern\u00e1ndez-Yumar A, et al. Genicular artery embolization for knee osteoarthritis: a systematic review with meta-analysis and cost-analysis. Gac Sanit. 2025 Feb. doi: 10.1016\/j.gaceta.2025.102459.<\/a><\/p>\n\n\n\n<p class=\"le-pub wp-block-paragraph\"><a href=\"https:\/\/doi.org\/10.31219\/osf.io\/8hqu2_v1\">Pre-print registration Update: del Pino-Sede\u00f1o, T., Hern\u00e1ndez, Y. G., de Armas-Castellano, A., Martin, M. T., &amp; Rojas-Reyes, M. X., for The Living Evidence to Inform Health Decision Research Group (LE-IHD). (2025, August 11). Genicular artery embolization for the treatment of knee osteoarthritis: a living systematic evidence synthesis (Update report).<\/a><\/p>\n<\/details>\n\n\n\n<details class=\"wp-block-details le-acc le-acc--repo is-layout-flow wp-block-details-is-layout-flow\"><summary>Eficacia y seguridad de la rehabilitaci\u00f3n card\u00edaca fuera del entorno hospitalario (atenci\u00f3n primaria, \u00e1mbito comunitario, domicilio) en pacientes con cardiopat\u00eda isqu\u00e9mica o insuficiencia card\u00edaca<\/summary>\n<p class=\"le-doc wp-block-paragraph\"><a href=\"\/pdfs\/PROTOCOL_LES_CardRehab_IschemHeartDis.pdf\" data-type=\"link\" data-id=\"\/pdfs\/PROTOCOL_LES_CardRehab_IschemHeartDis.pdf\">Protocol<\/a><\/p>\n\n\n\n<p class=\"le-doc wp-block-paragraph\"><a href=\"\/pdfs\/BASELINE_LES_CardiacRehabilitation_Living_Systematic_rev01082025.pdf\" data-type=\"link\" data-id=\"\/pdfs\/BASELINE_LES_CardiacRehabilitation_Living_Systematic_rev01082025.pdf\">Baseline Report<\/a><\/p>\n\n\n\n<p class=\"le-doc wp-block-paragraph\"><a href=\"\/pdfs\/Update_Synthesis_CardiacRehabilitation.pdf\" data-type=\"link\" data-id=\"\/pdfs\/Update_Synthesis_CardiacRehabilitation.pdf\">Updated Reports<\/a><\/p>\n\n\n\n<p class=\"le-doc wp-block-paragraph\"><a href=\"https:\/\/drive.google.com\/drive\/folders\/1XKtep3UcJYO4-a_QeAaJDhwz0fOBn-Zs\">Evidence Surveillance<\/a><\/p>\n\n\n\n<p class=\"le-doc wp-block-paragraph\">See in L.OVE<\/p>\n\n\n\n<p class=\"le-doc wp-block-paragraph\"><a href=\"https:\/\/app.iloveevidence.com\/loves\/6440522e13ada700083195b2?question_domain=5b1dcd8ae611de7ae84e8f14&amp;population=5d2756d7daeedf1d3af3332a&amp;intervention=64254f9b4fc01800099c3242&amp;classification=systematic-review\">Ischemic heart diseases<\/a><\/p>\n\n\n\n<p class=\"le-doc wp-block-paragraph\"><a href=\"https:\/\/app.iloveevidence.com\/loves\/595c3d3565dee07a6fff282b?question_domain=5b1dcd8ae611de7ae84e8f14&amp;population=5d2742ccdaeedf1d3af33329&amp;intervention=64254f9b4fc01800099c3242&amp;classification=systematic-review\">Heart failure<\/a><\/p>\n\n\n\n<p class=\"le-doc le-doc--label wp-block-paragraph\">Publicaciones<\/p>\n\n\n\n<p class=\"le-pub wp-block-paragraph\"><a href=\"https:\/\/doi.org\/10.31219\/osf.io\/ftn7q_v1\">Pre-print registration Update: Duarte-D\u00edaz, A., \u00c1lvarez-P\u00e9rez, Y., Santana, A. R., Perestelo-Perez, L., Martin, M. T., &amp; Rojas-Reyes, M. X., for The Living Evidence to Inform Health Decision Research Group (LE-IHD). (2025, August 11). Effectiveness and safety of out-of-hospital cardiac rehabilitation: a living systematic review (Update report).<\/a><\/p>\n<\/details>\n\n\n\n<details class=\"wp-block-details le-acc le-acc--repo is-layout-flow wp-block-details-is-layout-flow\"><summary>Cirug\u00eda citorreductora (CRS) combinada con quimioterapia intraperitoneal hipert\u00e9rmica (HIPEC) en pacientes pedi\u00e1tricos (&lt;14 o 18 a\u00f1os) con carcinomatosis peritoneal<\/summary>\n<p class=\"le-doc wp-block-paragraph\"><a href=\"\/pdfs\/PROTOCOL_LES_CRSandHIPEC_PeritCarcinom.pdf\" data-type=\"link\" data-id=\"\/pdfs\/PROTOCOL_LES_CRSandHIPEC_PeritCarcinom.pdf\">Protocol<\/a><\/p>\n\n\n\n<p class=\"le-doc wp-block-paragraph\"><a href=\"\/pdfs\/BASELINE_LES_CRS_vs_HIPEC.pdf\" data-type=\"link\" data-id=\"\/pdfs\/BASELINE_LES_CRS_vs_HIPEC.pdf\">Baseline Report<\/a><\/p>\n\n\n\n<p class=\"le-doc wp-block-paragraph\"><a href=\"https:\/\/drive.google.com\/drive\/folders\/1_nQU8A5k72-5lSVauM3I-x8cMXlWch5m\">Evidence Surveillance<\/a><\/p>\n\n\n\n<p class=\"le-doc wp-block-paragraph\"><a href=\"https:\/\/app.iloveevidence.com\/loves\/5e1a3db369c00e2adfdfead7?question_domain=5b1dcd8ae611de7ae84e8f14&amp;population=5d65406b69c00e507e1c88da&amp;intervention=642597e1168b060008b1742c&amp;classification=all\">See in L.OVE<\/a><\/p>\n\n\n\n<p class=\"le-doc le-doc--label wp-block-paragraph\">Publicaciones<\/p>\n\n\n\n<p class=\"le-pub wp-block-paragraph\"><a href=\"https:\/\/doi.org\/10.31219\/osf.io\/yp4dk_v1\">Pre-print registration Baseline: Ibargoyen-Roteta, N., Dom\u00ednguez Garc\u00eda, J., Jausoro, A., Galnares-Cordero, L., Rojas- Reyes, M. X., RN. for The Living Evidence to Inform Health Decision Research Group (LE-IHD). (2025, August 22). Cytoreductive Surgery (CRS) and Hyperthermic IntraPEritoneal Chemotherapy (HIPEC) versus palliative chemotherapy in pediatric patients with peritoneal carcinomatosis (&lt;18 years): a baseline report of a living systematic evidence synthesis.<\/a><\/p>\n<\/details>\n\n\n\n<details class=\"wp-block-details le-acc le-acc--repo is-layout-flow wp-block-details-is-layout-flow\"><summary>Profilaxis con vitamina D en comparaci\u00f3n con placebo o ausencia de profilaxis en pacientes con riesgo de infecci\u00f3n por SARS-CoV-2 o con COVID-19 leve, moderada o grave.<\/summary>\n<p class=\"le-doc wp-block-paragraph\"><a href=\"\/pdfs\/Protocol_VITAMIN%20D%20AETSA_Final%20version_030524.pdf\" data-type=\"link\" data-id=\"\/pdfs\/Protocol_VITAMIN%20D%20AETSA_Final%20version_030524.pdf\">Protocol<\/a><\/p>\n\n\n\n<p class=\"le-doc wp-block-paragraph\"><a href=\"\/pdfs\/Vitamin_D_in_COVID_LES_Baseline_report.pdf\" data-type=\"link\" data-id=\"\/pdfs\/Vitamin_D_in_COVID_LES_Baseline_report.pdf\">Baseline Report<\/a><\/p>\n\n\n\n<p class=\"le-doc wp-block-paragraph\"><a href=\"\/pdfs\/Vitamin_D_in_COVID_LES_Baseline_report.pdf\" data-type=\"link\" data-id=\"\/pdfs\/Vitamin_D_in_COVID_LES_Baseline_report.pdf\">Updated Reports<\/a><\/p>\n\n\n\n<p class=\"le-doc wp-block-paragraph\"><a href=\"https:\/\/drive.google.com\/drive\/folders\/1DVKbV4vjmSzI39Asurdo5mFFID5l1VNe\">Evidence Surveillance<\/a><\/p>\n\n\n\n<p class=\"le-doc wp-block-paragraph\">See in L.OVE<\/p>\n\n\n\n<p class=\"le-doc wp-block-paragraph\"><a href=\"https:\/\/app.iloveevidence.com\/loves\/5e6fdb9669c00e4ac072701d?question_domain=5b1dcd8ae611de7ae84e8f14&amp;population=5f180a1c3552583e3bc9e8be&amp;intervention=5d65854869c00e131b5a4c60&amp;intervention_variable=603b9fe03d05151f35cf13dc&amp;classification=all\">Covid<\/a><\/p>\n\n\n\n<p class=\"le-doc wp-block-paragraph\"><a href=\"https:\/\/app.iloveevidence.com\/loves\/5e6fdb9669c00e4ac072701d?question_domain=5b1dcd8ae611de7ae84e8f14&amp;population=5f1809fa69c00e5e2d82b225&amp;intervention=5d65854869c00e131b5a4c60&amp;intervention_variable=603b9fe03d05151f35cf13dc&amp;classification=all\">At risk of SARS-CoV-2 infection<\/a><\/p>\n\n\n\n<p class=\"le-doc le-doc--label wp-block-paragraph\">Publications<\/p>\n\n\n\n<p class=\"le-pub wp-block-paragraph\"><a href=\"https:\/\/doi.org\/10.1101\/2025.10.24.25338314\">Pre-print registration baseline: Sabalete, T., Blasco JA, Rodr\u00edguez R, Rosario MP, Rojas-Reyes MX for The Living Evidence to Inform Health Decision Research Group (LE-IHD). Efficacy and Safety of Vitamin D for COVID-19: A Living Evidence Synthesis Baseline report.<\/a><\/p>\n<\/details>\n\n\n\n<details class=\"wp-block-details le-acc le-acc--repo is-layout-flow wp-block-details-is-layout-flow\"><summary>La terapia biol\u00f3gica (anticuerpos monoclonales) puede administrarse en combinaci\u00f3n con otras intervenciones (LABA\/LAMA, ICS, rehabilitaci\u00f3n pulmonar) en adultos con EPOC.<\/summary>\n<p class=\"le-doc wp-block-paragraph\"><a href=\"\/pdfs\/PROTOCOL_LES_BiologicTher_COPD.pdf\" data-type=\"link\" data-id=\"\/pdfs\/PROTOCOL_LES_BiologicTher_COPD.pdf\">Protocol<\/a><\/p>\n\n\n\n<p class=\"le-doc wp-block-paragraph\"><a href=\"\/pdfs\/BASELINE_LES_Biological_Therapy_COPD_vMCL.pdf\" data-type=\"link\" data-id=\"\/pdfs\/BASELINE_LES_Biological_Therapy_COPD_vMCL.pdf\">Baseline Report<\/a><\/p>\n\n\n\n<p class=\"le-doc wp-block-paragraph\"><a href=\"https:\/\/drive.google.com\/drive\/folders\/1Ce7g9NqvLLA5KReZGNoG0Tp0FN8smAkx\">Evidence Surveillance<\/a><\/p>\n\n\n\n<p class=\"le-doc wp-block-paragraph\"><a href=\"https:\/\/app.iloveevidence.com\/loves\/5c87af8ac80dd42a1ac0c712?question_domain=5b1dcd8ae611de7ae84e8f14&amp;population=5d0b5bdedbe4d25bcfbee803&amp;intervention=642185205ef94100080f67b1&amp;classification=systematic-review\">See in L.OVE<\/a><\/p>\n\n\n\n<p class=\"le-doc le-doc--label wp-block-paragraph\">Publications<\/p>\n\n\n\n<p class=\"le-pub wp-block-paragraph\"><a href=\"https:\/\/doi.org\/10.1101\/2025.10.17.25337825\">Pre-print registration baseline: Olga Milena Garc\u00eda Morales, Ariadna Auladell, Daniel Poloni, Luz Angela Torres-L\u00f3pez, Laura D\u00edaz, Gerard Urr\u00fatia Couchi, Mar\u00eda Ximena Rojas-Reyes. Biological Therapy for Chronic Obstructive Pulmonary Disease (COPD): Efficacy and Safety medRxiv 2025.10.17.25337825<\/a><\/p>\n<\/details>\n\n\n\n<details class=\"wp-block-details le-acc le-acc--repo is-layout-flow wp-block-details-is-layout-flow\"><summary>Terapia combinada frente a monoterapia en el tratamiento de la hipertensi\u00f3n en adultos<\/summary>\n<p class=\"le-doc wp-block-paragraph\"><a href=\"\/pdfs\/Protocol_01052025_Combined_therapy_Hypertension_SESCS_Final_version.pdf\" data-type=\"link\" data-id=\"\/pdfs\/Protocol_01052025_Combined_therapy_Hypertension_SESCS_Final_version.pdf\">Protocol<\/a><\/p>\n\n\n\n<p class=\"le-doc wp-block-paragraph\">Baseline Report<\/p>\n\n\n\n<p class=\"le-doc wp-block-paragraph\">Updated Reports<\/p>\n\n\n\n<p class=\"le-doc wp-block-paragraph\"><a href=\"https:\/\/docs.google.com\/spreadsheets\/d\/1lFFaK8J4Qy66YUQ5CxLS6tfkssayrNbk\/edit?usp=drive_link&amp;ouid=109237694833234518948&amp;rtpof=true&amp;sd=true\">Evidence Surveillance<\/a><\/p>\n\n\n\n<p class=\"le-doc wp-block-paragraph\">See in L.OVE<\/p>\n\n\n\n<p class=\"le-doc le-doc--label wp-block-paragraph\">Publications<\/p>\n<\/details>\n\n\n\n<details class=\"wp-block-details le-acc le-acc--repo is-layout-flow wp-block-details-is-layout-flow\"><summary>An\u00e1logos y agonistas del p\u00e9ptido similar al glucag\u00f3n en la diabetes mellitus tipo 2<\/summary>\n<p class=\"le-doc wp-block-paragraph\"><a href=\"\/pdfs\/PROTOCOL_LES_GlucagLikePeptAnalog_DM2.pdf\" data-type=\"link\" data-id=\"\/pdfs\/PROTOCOL_LES_GlucagLikePeptAnalog_DM2.pdf\">Protocol<\/a><\/p>\n\n\n\n<p class=\"le-doc wp-block-paragraph\"><a href=\"\/pdfs\/BASELINE_LES_%20GlucagLikePeptAnalog_DM2.pdf\" data-type=\"link\" data-id=\"\/pdfs\/BASELINE_LES_%20GlucagLikePeptAnalog_DM2.pdf\">Baseline Report<\/a><\/p>\n\n\n\n<p class=\"le-doc wp-block-paragraph\"><a href=\"\/pdfs\/UPDATE_REPORT_LES_GlucagPeptAnalog_DM2.pdf\" data-type=\"link\" data-id=\"\/pdfs\/UPDATE_REPORT_LES_GlucagPeptAnalog_DM2.pdf\">Updated Reports<\/a><\/p>\n\n\n\n<p class=\"le-doc wp-block-paragraph\"><a href=\"https:\/\/drive.google.com\/drive\/folders\/1mqyM1LkApYYHefiZNSe6Z9j_Jxcj_aYS\">Evidence Surveillance<\/a><\/p>\n\n\n\n<p class=\"le-doc wp-block-paragraph\"><a href=\"https:\/\/app.iloveevidence.com\/loves\/5b7e78ddc80dd4376f2b3dd5?question_domain=5b1dcd8ae611de7ae84e8f14&amp;population=5d52919a69c00e3de733d81f&amp;intervention=5d67d29d69c00e131b5a4cad&amp;classification=systematic-review\">See in L.OVE<\/a><\/p>\n\n\n\n<p class=\"le-doc le-doc--label wp-block-paragraph\">Publications<\/p>\n<\/details>\n\n\n\n<details class=\"wp-block-details le-acc le-acc--repo is-layout-flow wp-block-details-is-layout-flow\"><summary>Detecci\u00f3n y manejo de infecciones del torrente sangu\u00edneo y\/o sepsis por microorganismos multirresistentes (MDR) mediante diagn\u00f3stico molecular r\u00e1pido y m\u00e9todos basados \u200b\u200ben cultivos<\/summary>\n<p class=\"le-doc wp-block-paragraph\"><a href=\"\/pdfs\/Protocol%20AMR_OSTEBA_27052024.pdf\" data-type=\"link\" data-id=\"\/pdfs\/Protocol%20AMR_OSTEBA_27052024.pdf\">Protocol<\/a><\/p>\n\n\n\n<p class=\"le-doc wp-block-paragraph\"><a href=\"\/pdfs\/Baseline_Detection_bloodstream_infection.pdf\" data-type=\"link\" data-id=\"\/pdfs\/Baseline_Detection_bloodstream_infection.pdf\">Baseline Report<\/a><\/p>\n\n\n\n<p class=\"le-doc le-doc--label wp-block-paragraph\">Publications<\/p>\n\n\n\n<p class=\"le-pub wp-block-paragraph\"><a href=\"https:\/\/doi.org\/10.31219\/osf.io\/tu5ws_v1\">Pre-print registration baseline: Rada, I., Guti\u00e9rrez G\u00f3mez, E., Benguria, G., Imeshtari, V., Ibargoyen-Roteta, N., Galnares-Cordero, L., &amp; Rojas-Reyes, M. X., for The Living Evidence to Inform Health Decision Research Group (LE-IHD). (2025, August 22). Enhancing detection and management of bloodstream infection and\/or sepsis caused by multi-drug resistant microorganisms integrating rapid molecular diagnostic tests and culture-based methods. A living Evidence Synthesis.<\/a><\/p>\n<\/details>\n\n\n\n<hr class=\"wp-block-separator has-text-color has-alpha-channel-opacity has-background le-hr is-style-wide\" style=\"background-color:#9acc32;color:#9acc32\"\/>\n\n\n\n<h3 class=\"wp-block-heading le-sub-title\">Resuelta<\/h3>\n\n\n\n<div style=\"height:10px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<details class=\"wp-block-details le-acc le-acc--repo is-layout-flow wp-block-details-is-layout-flow\"><summary>Trasplante de microbiota fecal para la colitis ulcerosa<\/summary>\n<p class=\"le-doc wp-block-paragraph\"><a href=\"\/pdfs\/PROTOCOL-LES_FecalMicrobTransp_%20UlceratColitis_living%20overview.pdf\" data-type=\"link\" data-id=\"\/pdfs\/PROTOCOL-LES_FecalMicrobTransp_%20UlceratColitis_living%20overview.pdf\">Protocol<\/a><\/p>\n\n\n\n<p class=\"le-doc wp-block-paragraph\"><a href=\"\/pdfs\/BASELINE_FecalMicrobTransp_%20UlceratColitis_living%20overview.pdf\" data-type=\"link\" data-id=\"\/pdfs\/BASELINE_FecalMicrobTransp_%20UlceratColitis_living%20overview.pdf\">Baseline Report<\/a><\/p>\n\n\n\n<p class=\"le-doc wp-block-paragraph\"><a href=\"\/pdfs\/UPDATE_FecalMicrobTransp_%20UlceratColitis_living%20overview.pdf\" data-type=\"link\" data-id=\"\/pdfs\/UPDATE_FecalMicrobTransp_%20UlceratColitis_living%20overview.pdf\">Updated Report<\/a><\/p>\n\n\n\n<p class=\"le-doc wp-block-paragraph\"><a href=\"https:\/\/app.iloveevidence.com\/loves\/5b5f2f63c80dd41ff5583f36?question_domain=5b1dcd8ae611de7ae84e8f14&amp;population=5d52970369c00e3de533d807&amp;intervention=5d9f92b83c12ef4de3dce659&amp;classification=systematic-review\">See in L.OVE<\/a><\/p>\n<\/details>\n\n\n\n<details class=\"wp-block-details le-acc le-acc--repo is-layout-flow wp-block-details-is-layout-flow\"><summary>Dispositivos de asistencia mec\u00e1nica en enfermedades cardiovasculares<\/summary>\n<p class=\"le-doc wp-block-paragraph\"><a href=\"\/pdfs\/Protocol_Mechanical.docx.pdf\" data-type=\"link\" data-id=\"\/pdfs\/Protocol_Mechanical.docx.pdf\">Protocol<\/a><\/p>\n\n\n\n<p class=\"le-doc wp-block-paragraph\"><a href=\"\/pdfs\/NEW%20BASELINE-Mechanical%20assist%20devices.docx.pdf\" data-type=\"link\" data-id=\"\/pdfs\/NEW%20BASELINE-Mechanical%20assist%20devices.docx.pdf\">Baseline Report<\/a><\/p>\n\n\n\n<p class=\"le-doc wp-block-paragraph\">Updated Report<\/p>\n\n\n\n<p class=\"le-doc wp-block-paragraph\"><a href=\"https:\/\/app.iloveevidence.com\/loves\/60be456f35525860bb2a3a02?question_domain=5b1dcd8ae611de7ae84e8f14&amp;population=5d27427edaeedf1d3af33328&amp;intervention=60ad7996355258737783d474&amp;classification=all\">See in L.OVE<\/a><\/p>\n<\/details>\n\n\n\n<details class=\"wp-block-details le-acc le-acc--repo is-layout-flow wp-block-details-is-layout-flow\"><summary>Mamograf\u00eda tridimensional para el c\u00e1ncer de mama<\/summary>\n<p class=\"le-doc wp-block-paragraph\"><a href=\"\/pdfs\/Protocol_Tridimentional-BreastCa.pdf\" data-type=\"link\" data-id=\"\/pdfs\/Protocol_Tridimentional-BreastCa.pdf\">Protocol<\/a><\/p>\n\n\n\n<p class=\"le-doc wp-block-paragraph\">Baseline Report<\/p>\n\n\n\n<p class=\"le-doc wp-block-paragraph\">Updated Report<\/p>\n\n\n\n<p class=\"le-doc wp-block-paragraph\"><a href=\"https:\/\/app.iloveevidence.com\/loves\/598e0a2b65dee02d5eede318?question_domain=5b1dccf3e611de7ae84e8f12&amp;population=5d07efb1dbe4d25bcebee227&amp;intervention=5e66a2403d051578b5c8b494&amp;classification=systematic-review\">See in L.OVE<\/a><\/p>\n<\/details>\n\n\n\n<details class=\"wp-block-details le-acc le-acc--repo is-layout-flow wp-block-details-is-layout-flow\"><summary>Bevacizumab, olaparib, rucaparib y niraparib para el c\u00e1ncer de ovario<\/summary>\n<p class=\"le-doc wp-block-paragraph\"><a href=\"\/pdfs\/PROTOCOLO_LES_TargeTher_OvarianCa.pdf\" data-type=\"link\" data-id=\"\/pdfs\/PROTOCOLO_LES_TargeTher_OvarianCa.pdf\">Protocol<\/a><\/p>\n\n\n\n<p class=\"le-doc wp-block-paragraph\"><a href=\"\/pdfs\/BASELINE_LES_TargeTher_OvarianCa..pdf\" data-type=\"link\" data-id=\"\/pdfs\/BASELINE_LES_TargeTher_OvarianCa..pdf\">Baseline Report<\/a><\/p>\n\n\n\n<p class=\"le-doc wp-block-paragraph\"><a href=\"\/pdfs\/UPDATE_LES_TargeTher_OvarianCa.pdf\" data-type=\"link\" data-id=\"\/pdfs\/UPDATE_LES_TargeTher_OvarianCa.pdf\">Updated Report<\/a><\/p>\n\n\n\n<p class=\"le-doc wp-block-paragraph\">See in L.OVE<\/p>\n\n\n\n<p class=\"le-doc wp-block-paragraph\"><a href=\"https:\/\/app.iloveevidence.com\/loves\/5ea7378c3d0515415050441e?question_domain=5b1dcd8ae611de7ae84e8f14&amp;population=5ea737633d0515415050441d&amp;intervention=5d37695adaeedf04f2da5f95&amp;classification=all\">Bevacizumab<\/a><\/p>\n\n\n\n<p class=\"le-doc wp-block-paragraph\"><a href=\"https:\/\/app.iloveevidence.com\/loves\/5ea7378c3d0515415050441e?question_domain=5b1dcd8ae611de7ae84e8f14&amp;population=5ea737633d0515415050441d&amp;intervention=60423b7c3d051526aac19829&amp;classification=all\">Olaparib<\/a><\/p>\n\n\n\n<p class=\"le-doc wp-block-paragraph\"><a href=\"https:\/\/app.iloveevidence.com\/loves\/5ea7378c3d0515415050441e?question_domain=5b1dcd8ae611de7ae84e8f14&amp;population=5ea737633d0515415050441d&amp;intervention=60423c3569c00e308796de9e&amp;classification=all\">Niraparib<\/a><\/p>\n\n\n\n<p class=\"le-doc wp-block-paragraph\"><a href=\"https:\/\/app.iloveevidence.com\/loves\/5ea7378c3d0515415050441e?question_domain=5b1dcd8ae611de7ae84e8f14&amp;population=5ea737633d0515415050441d&amp;intervention=60423be23d051526a8c15c41&amp;classification=all\">Rucaparib<\/a><\/p>\n<\/details>\n<\/div>\n\n\n\n<p class=\"has-text-align-center wp-block-paragraph\">Este sitio web es mantenido y actualizado peri\u00f3dicamente por AT INFORM\u00c0TICA SCCL \u2013 NIF: F17517376 \u2013 <a href=\"mailto:resteve@atigirona.com\">resteve@atigirona.com<\/a> \u00daltima actualizaci\u00f3n el 4 de noviembre de 2025.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Repositorio LE-Synthesis El programa LE-IHD ha apoyado el desarrollo de diversas s\u00edntesis de evidencia viva por parte de distintas organizaciones. Mediante este repositorio de acceso gratuito, respaldamos el ecosistema de la evidencia al evitar la duplicaci\u00f3n de esfuerzos entre grupos, y fomentamos la reutilizaci\u00f3n de la evidencia en los procesos de generaci\u00f3n y adaptaci\u00f3n de [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":40,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-263","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/livingevidenceihd.com\/es\/wp-json\/wp\/v2\/pages\/263","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/livingevidenceihd.com\/es\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/livingevidenceihd.com\/es\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/livingevidenceihd.com\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/livingevidenceihd.com\/es\/wp-json\/wp\/v2\/comments?post=263"}],"version-history":[{"count":2,"href":"https:\/\/livingevidenceihd.com\/es\/wp-json\/wp\/v2\/pages\/263\/revisions"}],"predecessor-version":[{"id":266,"href":"https:\/\/livingevidenceihd.com\/es\/wp-json\/wp\/v2\/pages\/263\/revisions\/266"}],"wp:attachment":[{"href":"https:\/\/livingevidenceihd.com\/es\/wp-json\/wp\/v2\/media?parent=263"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}